Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01163942
Recruitment Status : Terminated (Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was too slow.)
First Posted : July 16, 2010
Last Update Posted : April 3, 2015
CHUGAI sanofi-aventis
Information provided by (Responsible Party):
European Group for Blood and Marrow Transplantation